0000000001070788

AUTHOR

Anna Lanzoni

showing 10 related works from this author

The GENDER ATTENTION Observational Study: Gender and Hormonal Status Differences in the Incidence of Adverse Events During Cyclosporine Treatment in …

2017

Introduction: Female sex has been shown to be a risk factor for the development of adverse drug reactions; however, this has not been studied for cyclosporine (CsA). The aim of this study was to investigate, in Italian dermatological practice, the influence of gender and menopause and related hormones on the incidence of adverse events (AEs) during CsA treatment in psoriatic patients. Methods: Multicenter, prospective, observational study conducted from May 2011 to June 2013. Patients with plaque psoriasis, undergoing a new CsA administration course, or about to start it, were enrolled in the outpatient clinics of Italian dermatological centers. During the 2–6 months of study duration, pati…

MaleSex FactorRate ratio030226 pharmacology & pharmacyGonadal Steroid HormoneSeverity of Illness Index0302 clinical medicineOutpatient clinicAdverse drug reaction; Cyclosporine; Dermatology; Female; Gender; PsoriasisPharmacology (medical)030212 general & internal medicineProspective StudiesProspective cohort studyGonadal Steroid HormonesOriginal ResearchIncidence (epidemiology)IncidenceMedicine (all)General MedicineMiddle AgedMenopausePostmenopauseItalyCyclosporineFemaleSettore MED/35 - MALATTIE CUTANEE E VENEREEHumanAdultmedicine.medical_specialtyAdolescentAdverse drug reaction; Cyclosporine; Dermatology; Female; Gender; Psoriasis; Adolescent; Adult; Cyclosporine; Female; Gonadal Steroid Hormones; Humans; Incidence; Italy; Male; Middle Aged; Postmenopause; Prospective Studies; Psoriasis; Severity of Illness Index; Sex Factors; Young Adult; Pharmacology (medical)Adverse drug reactionDermatology03 medical and health sciencesYoung AdultSex FactorsInternal medicineSeverity of illnessmedicineHumansPsoriasisRisk factorAdverse effectPsoriasibusiness.industryGendermedicine.diseaseSurgeryAdverse drug reaction; Cyclosporine; Dermatology; Female; Gender; Psoriasis; Medicine (all); Pharmacology (medical)Prospective StudiebusinessAdverse drug reaction; Cyclosporine; Dermatology; Female; Gender; Psoriasis;
researchProduct

Statement complementing the EFSA Scientific Opinion on application (EFSA‐GMO‐DE‐2011‐95) for the placing on the market of genetically modified maize …

2018

Abstract The GMO Panel was previously not in the position to complete the food/feed safety assessment of maize 5307 due to an inadequate 28‐day toxicity study necessary for an appropriate assessment of eCry3.1Ab protein. Following a mandate from the European Commission, the GMO Panel assessed a supplementary 28‐day toxicity study in mice on the eCry3.1Ab protein (1,000 mg/kg body weight (bw) per day) to complement its scientific opinion on application EFSA‐GMO‐DE‐2011‐95 for the placing on the market of the maize 5307 for food and feed uses, import and processing. The supplementary 28‐day toxicity study did not show adverse effects. Taking into account the previous assessment and the new in…

040301 veterinary sciencesVeterinary (miscellaneous)[SDV]Life Sciences [q-bio]2405 Parasitology28‐day studyPlant ScienceTP1-1185010501 environmental sciencesBody weight01 natural sciencesMicrobiology0403 veterinary scienceimport and processing1110 Plant ScienceEuropean commissionTX341-6411106 Food Science0105 earth and related environmental sciences2. Zero hungerGenetically modified maizebusiness.industryNutrition. Foods and food supplyGMOChemical technology2404 Microbiologyfungi10079 Institute of Veterinary Pharmacology and Toxicology04 agricultural and veterinary sciencesfood and feed safetyeCry3.1AbBiotechnologyCrop protection3401 Veterinary (miscellaneous)Scientific OpinionSettore AGR/11 - Entomologia Generale E Applicata570 Life sciences; biologyAnimal Science and ZoologyParasitologymaize 53071103 Animal Science and Zoologybusiness28-day studyFood Science
researchProduct

Assessment of genetically modified cotton GHB614 × T304‐40 × GHB119 for food and feed uses, import and processing under Regulation (EC) No 1829/2003 …

2018

International audience; The three-event stack cotton GHB614 x T304-40 x GHB119 was produced by conventional crossing to combine three single events, GHB614, T304-40 and GHB119. The genetically modified organisms (GMO) Panel previously assessed the three single cotton events and did not identify safety concerns. No new data on the single cotton events that could lead to modification of the original conclusions on their safety were identified. Based on the molecular, agronomic, phenotypic and compositional characteristics, the combination of the single cotton events and of the newly expressed proteins in the three-event stack cotton did not give rise to food and feed safety concern. The GMO P…

Veterinary (miscellaneous)[SDV]Life Sciences [q-bio]2405 ParasitologyPlant Science010501 environmental sciencesBiology01 natural sciencesMicrobiology[SHS]Humanities and Social Sciences1110 Plant Science[SDV.IDA]Life Sciences [q-bio]/Food engineering[SDV.BV]Life Sciences [q-bio]/Vegetal Biology[SPI.GPROC]Engineering Sciences [physics]/Chemical and Process EngineeringCry1Ab1106 Food Science0105 earth and related environmental sciencesCry2Ae2. Zero hungerbusiness.industryGMO2404 MicrobiologyRegulation (EC) 1829/200304 agricultural and veterinary sciences10079 Institute of Veterinary Pharmacology and ToxicologyGenetically modified organismBiotechnology3401 Veterinary (miscellaneous)Scientific Opinion[SDE]Environmental Sciences040103 agronomy & agriculture0401 agriculture forestry and fisheries570 Life sciences; biologyAnimal Science and ZoologyParasitologycotton GHB614 x T304-40 x GHB1191103 Animal Science and Zoologybusiness2mEPSPSPATFood Science
researchProduct

Assessment of genetically modified maize 1507 × 59122 × MON810 × NK603 and subcombinations, for food and feed uses, under Regulation (EC) No 1829/200…

2017

In this opinion, the GMO Panelassessed the four-event stack maize 1507 x 59122 x MON810 x NK603 and its ten subcombinations, independently of their origin. The GMO Panelpreviously assessed the four single events combined in this four-event stack maize and five of their combinations and did not identify safety concerns. No new data on the single events or their previously assessed combinations leading to modification of the original conclusions were identified. Based on the molecular, agronomic, phenotypic and compositional characteristics, the combination of the single maize events and of the newly expressed proteins in the four-event stack maize did not give rise to food and feed safety or…

0106 biological sciencesmaïs[SDV]Life Sciences [q-bio]Veterinary (miscellaneous)ogmPlant Science010501 environmental sciencesBiology01 natural sciencesMicrobiologyProtein expression1507 x 59122 x MON810 x NK603Environmental safety[SDV.IDA]Life Sciences [q-bio]/Food engineering[SDV.BV]Life Sciences [q-bio]/Vegetal Biology[SPI.GPROC]Engineering Sciences [physics]/Chemical and Process Engineeringinsect resistant and herbicide tolerantmaize (Zea mays)0105 earth and related environmental sciences2. Zero hungerGenetically modified maizeGMO;maize (Zea mays);1507 x 59122 x MON810 x NK603;insect resistant and herbicide tolerant;Regulation (EC) No 1829/2003GMObusiness.industryRegulation (EC) No 1829/2003BiotechnologyScientific OpinionAgronomyRegulation (EC) No1829/2003Animal Science and ZoologyParasitology1507 × 59122 ×  MON810 ×  NK603businessRegulation (EC) No 1829/2003010606 plant biology & botanyFood ScienceEFSA Journal
researchProduct

Assessment of genetically modified maize MON 87411 for food and feed uses, import and processing, under Regulation (EC) No 1829/2003 (application EFS…

2018

Maize MON 87411 was developed to confer resistance to corn rootworms (Diabrotica spp.) by the expression of a modified version of the Bacillus thuringiensis cry3Bb1 gene and a DvSnf7 dsRNA expression cassette, and tolerance to glyphosate-containing herbicides by the expression of a CP4 5-enolpyruvylshikimate-3-phosphate synthase (cp4 epsps) gene. The molecular characterisation data and bioinformatics analyses did not identify issues requiring assessment for food and feed safety. No statistically significant differences in the agronomic and phenotypic characteristics tested between maize MON 87411 and its conventional counterpart were identified. The compositional analysis of maize MON 87411…

0301 basic medicineCry3Bb1DvSnf7Cry3Bb1Veterinary (miscellaneous)[SDV]Life Sciences [q-bio]TP1-1185Plant Science010501 environmental sciences01 natural sciencesMicrobiology03 medical and health sciencesPlant scienceEnvironmental safetyBacillus thuringiensisTX341-641Diabroticamaize (Zea mays)0105 earth and related environmental sciences2. Zero hungerGenetically modified maizeCP4 EPSPSbiologyAnimal healthNutrition. Foods and food supplybusiness.industryGMOChemical technologyRegulation (EC) No 1829/2003biology.organism_classificationFood safetyMON 87411BiotechnologyScientific Opinion030104 developmental biologyAnimal Science and ZoologyParasitologybusinessRegulation (EC) No 1829/2003Food Science
researchProduct

Italian Euromelanoma Day Screening Campaign (2005-2007) and the planning of melanoma screening strategies.

2011

Although no study has definitively shown that unfocused screening of skin cancer is effective, many campaigns have been organized with the aim of increasing awareness on melanoma risk factors. The objective of this study was to analyse the results of the Skin Cancer Screening Day in Italy during the period 2005-2007, to determine the priorities for melanoma control plans in a Mediterranean country. A total of 5002 patients were screened by dermatologists in 31 cities. Individuals who considered themselves to have many naevi and those with a family history of melanoma showed a higher number of common and atypical naevi. Ten melanomas, 20 basal cell carcinomas and two squamous cell carcinomas…

Program evaluationMaleCancer ResearchSkin NeoplasmsTime FactorsEpidemiologyBasal CellpreventionRisk Factorsself-surveillance80 and overSettore MED/35 - Malattie Cutanee E VenereeMedicineMass Screeningmelanoma screening campaignMelanoma prevention strategy Melanoma risk factors Melanoma screening campaign Self-surveillance Skin cancerFamily historyYoung adultChildMelanomaAged 80 and overeducation.field_of_studyNevus Pigmentedskin cancerMelanomaMiddle AgedMALIGNANT MELANOMA; screeningPrognosisOncologyItalymelanoma; screening; risk factors; prevention; prognosisChild PreschoolCarcinoma Squamous CellFemaleAdultmedicine.medical_specialtyAdolescentPopulationmelanoma prevention strategy; melanoma risk factors; melanoma screening campaign; self-surveillance; skin cancermelanoma prevention strategyYoung AdultPigmentedHumansmelanoma prevention strategy; melanoma risk factors; melanoma screening campaign; skin cancer; self-surveillancePreschooleducationNevusSocioeconomic statusMass screeningAgedbusiness.industrymelanoma risk factorsscreeningCarcinomaPublic Health Environmental and Occupational Healthmelanoma risk factorInfantmedicine.diseaseDermatologyMALIGNANT MELANOMASquamous CellCarcinoma Basal CellSelf-ExaminationSkin cancerbusinessProgram Evaluation
researchProduct

Assessment of genetically modified maize 4114 for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐NL‐2014‐123)

2018

Abstract Maize 4114 was developed through Agrobacterium tumefaciens‐mediated transformation to provide protection against certain lepidopteran and coleopteran pests by expression of the Cry1F, Cry34Ab1 and Cry35Ab1 proteins derived from Bacillus thuringiensis, and tolerance to the herbicidal active ingredient glufosinate‐ammonium by expression of the PAT protein derived from Streptomyces viridochromogenes. The molecular characterisation data did not identify issues requiring assessment for food/feed safety. None of the compositional, agronomic and phenotypic differences identified between maize 4114 and the non‐genetically modified (GM) comparator(s) required further assessment. There were …

0106 biological sciences4114herbicide toleranceAgrobacteriumCry1F[SDV]Life Sciences [q-bio]Veterinary (miscellaneous)Cry34Ab1Context (language use)4114; Cry1F; Cry34Ab1; Cry35Ab1; GMO; herbicide tolerance; insect-resistant; maize (Zea mays); PAT; Regulation (EC) No 1829/2003TP1-1185Plant Science010501 environmental sciences01 natural sciencesMicrobiologyBacillus thuringiensisinsect‐resistantinsect-resistantTX341-641maize (Zea mays)0105 earth and related environmental sciences2. Zero hungerGenetically modified maizeAnimal healthbiologyNutrition. Foods and food supplyGMObusiness.industryChemical technologyCry35Ab1Regulation (EC) No 1829/2003maize (Zea mays)biology.organism_classificationGenetically modified organismBiotechnologyTransformation (genetics)Scientific Opinion13. Climate actionAnimal Science and ZoologyParasitologybusinessCry 1FPATRegulation (EC) No 1829/2003010606 plant biology & botanyFood SciencePotential toxicity
researchProduct

Assessment of genetically modified maize Bt11 x MIR162 x 1507 x GA21 and three subcombinations independently of their origin, for food and feed uses …

2018

In this opinion, the GMO Panel assessed the four-event stack maize Btll x MIR162 x 1507 x GA21 and three of its subcombinations, independently of their origin. The GMO Panel previously assessed the four single events and seven of their combinations and did not identify safety concerns. No new data on the single events or the seven subcombinations leading to modification of the original conclusions were identified. Based on the molecular, agronomic, phenotypic and compositional characteristics, the combination of the single events in the four-event stack maize did not give rise to food/feed safety issues. Based on the nutritional assessment of the compositional characteristics of maize Btll …

0106 biological sciencesVeterinary (miscellaneous)[SDV]Life Sciences [q-bio]Context (language use)Plant Science010501 environmental sciencesBiology01 natural sciencesMicrobiologyGA21Plant scienceEnvironmental safetyinsect resistant and herbicide tolerantmaize (Zea mays)15070105 earth and related environmental sciences2. Zero hungerGenetically modified maizebusiness.industryGMOMIR162Bt11BiotechnologyGenetically modified organismScientific OpinionAnimal Science and ZoologyParasitologybusiness010606 plant biology & botanyFood Science
researchProduct

Guidance for the risk assessment of the presence at low level of genetically modified plant material in imported food and feed under Regulation (EC) …

2017

Abstract This document provides guidance for the risk assessment under Regulation (EC) No 1829/2003 of the unintended, adventitious or technically unavoidable presence in food and feed of low level of genetically modified plant material intended for markets other than in the European Union. In this context, the presence at low level is defined to be maximum 0.9% of genetically modified plant material per ingredient. This guidance is intended to assist applicants by indicating which scientific requirements of Annex II of Regulation (EU) No 503/2013 are considered necessary for the risk assessment of the presence at low levels of genetically modified plant material in food and feed.

0106 biological sciencesVeterinary (miscellaneous)[SDV]Life Sciences [q-bio]Context (language use)Plant ScienceGenetically modified crops010501 environmental sciences01 natural sciencesMicrobiologyRegulation (EU) No 503/2013Ingredientpresence at low level[SDV.IDA]Life Sciences [q-bio]/Food engineeringmedia_common.cataloged_instance[SDV.BV]Life Sciences [q-bio]/Vegetal BiologySettore AGR/18 - Nutrizione E Alimentazione Animale[SPI.GPROC]Engineering Sciences [physics]/Chemical and Process EngineeringEuropean unionfood/feed0105 earth and related environmental sciencesmedia_commonguidance;GMO;presence at low level;risk assessment;Regulation (EC) No 1829/2003;Regulation (EU) No 503/2013;food/feedbusiness.industryGMORegulation (EC) No 1829/2003risk assessmentguidance; GMO; presence at low level; risk assessment; Regulation (EC) No 1829/2003; Regulation (EU) No 503/2013; food/feed10079 Institute of Veterinary Pharmacology and ToxicologyFood safetyBiotechnologyRegulation (EU) No 503/2013Scientific OpinionSettore AGR/11 - Entomologia Generale E Applicata570 Life sciences; biologyAnimal Science and ZoologyParasitologyRisk assessmentbusinessguidanceRegulation (EC) No 1829/2003010606 plant biology & botanyFood Science
researchProduct

Assessment of genetically modified maize 1507 × NK603 for renewal of authorisation under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐RX‐008)

2018

International audience; Following the submission of application EFSA-GMO-RX-008 under Regulation (EC) No 1829/2003 from Pioneer Hi-Bred International, Inc. and Dow AgroSciences LLC, the Panel on Genetically Modified Organisms of the European Food Safety Authority was asked to deliver a scientific risk assessment on the data submitted in the context of the renewal of authorisation application for the insect-resistant, herbicide-tolerant genetically modified maize 1507 x NK603, for food and feed uses, import and processing, excluding cultivation within the EU. The data received in the context of this renewal application contained a systematic search and evaluation of literature, updated bioin…

0301 basic medicineVeterinary (miscellaneous)[SDV]Life Sciences [q-bio]Plant Science010501 environmental sciences01 natural sciencesMicrobiology[SHS]Humanities and Social Sciences03 medical and health sciences1507 × NK603[SDV.IDA]Life Sciences [q-bio]/Food engineering[SDV.BV]Life Sciences [q-bio]/Vegetal Biology[SPI.GPROC]Engineering Sciences [physics]/Chemical and Process Engineering0105 earth and related environmental sciences2. Zero hungerrenewalGmoRegulation (EC) No 1829/2003Maize030104 developmental biologyScientific Opinion[SDE]Environmental Sciences1507 x NK603ParasitologyAnimal Science and ZoologyArticles 11 and 23Food ScienceRegulation (EC) No 1829/2003
researchProduct